Company Filing History:
6 out of 37 
1 out of 5,307 
1 out of 1 Years Active: 2005-2016
Title: Ansgar Santel: Innovator in Pharmaceutical Sciences
Introduction
Ansgar Santel is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compositions and methods for therapeutic applications. With a total of nine patents to his name, Santel's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, one notable invention is related to lipids and lipid complexes. This invention focuses on the uses of a composition that includes a pharmaceutically active component and a specific compound. Another significant patent involves means for inhibiting the expression of ANG2. This invention describes an siRNA that comprises both an antisense strand and a sense strand, with specific nucleotide sequences designed for therapeutic efficacy.
Career Highlights
Ansgar Santel has worked with notable organizations, including Silence Therapeutics GmbH and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate on cutting-edge research and development projects, further enhancing his expertise in the field.
Collaborations
Throughout his career, Santel has collaborated with esteemed colleagues such as Oliver Keil and Jörg Kaufmann. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Ansgar Santel's innovative work in pharmaceutical sciences showcases his dedication to advancing medical treatments through his inventions. His contributions, particularly in the areas of lipid compositions and siRNA technology, highlight the importance of research and collaboration in the field.